2024.03.05
Advances in cancer DNA methylation analysis with methPLIER: use of non-negative matrix factorization and knowledge-based constraints to enhance biological interpretability(March 5, 2024)
- Technologies
- Machine learning
- RIKEN Center for Advanced Intelligence Project (AIP)
- https://aip.riken.jp/news/20240305_pressrelease_hamamoto-t/?lang=en
A research paper, entitled "Advances in cancer DNA methylation analysis with methPLIER: use of non-negative matrix factorization and knowledge-based constraints to enhance biological interpretability" was published in the Experimental & Molecular Medicine.
The research team includes Ken Takasawa (Research Scientist), Ryuji Hamamoto (Team Leader) of the Cancer Translational Research Team, at RIKEN AIP.
For more information, please see the RIKEN AIP website.
https://aip.riken.jp/news/20240305_pressrelease_hamamoto-t/?lang=en
Technologies
1